Skip to content
★ Sign in to follow
GF

Greg Flynn

UDG Healthcare plc
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€56k

Latest filing published 05 Feb 2021 for UDG Healthcare plc, €56k.

Filing timeline

BuySale
Greg Flynn

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Greg Flynn: trading record in brief

This profile gathers the share dealings of Greg Flynn in UDG Healthcare plc. We count 3 filings; the first trade dates from 4 December 2019 and the latest from 2 February 2021.

No open-market purchase appears, only 1 sale worth €56k. Outside the open market, there are 2 share grants. Since January 2021: no purchases and 1 sale on the market.

On 5 February 2021 came the latest disclosure, an open-market sale for €56k in UDG Healthcare plc. Typically, a trade is published a median of 2 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Greg Flynn

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    PDMR - Global President, Ashfield Engage - UDG Healthcare plcExecutivesUDG Healthcare plc
    49,375 GBP42FCA-NSM
    11,714 shares@ £4.21595.0% of flowLondon Stock Exchange, Main MarketISIN IE0033024807FCA-NSM:3870291-0
  • ◆
    PDMR -President of Ashfield Commercial & CommercialExecutivesUDG Healthcare plc
    €1,48630FCA-NSM
    29,719 shares@ €0.05100.0% of flowLondon Stock Exchange, Main MarketISIN IE0033024807FCA-NSM:3804760-5
  • ◆
    PDMR - Global Head of Ashfield Commercial & Medical Services - UDG Healthcare plcExecutivesUDG Healthcare plc
    €1,45116FCA-NSM
    29,029 shares@ €0.0549.4% of flowLondon Stock Exchange, Main MarketISIN IE0033024807FCA-NSM:LSE20191206142036_14339356_20200326185106078_23217-2

3 of 3 declarations